Iovance Biotherapeutics, Inc. (United States) is linked to 1 FDA-registered manufacturing site. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Iovance Biotherapeutics, Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/iovance-biotherapeutics-inc

Overview

Iovance Biotherapeutics, Inc. is a biotechnology company focused on developing and commercializing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology. The company's therapies are designed to harness a patient's own immune system to eliminate cancer cells.

Therapeutic areas

Registered manufacturing sites (1)

Physical sites registered with the US FDA and resolved to Iovance Biotherapeutics, Inc., with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Iovance Biotherapeutics, Inc. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this Iovance Biotherapeutics, Inc.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.